Collaborations & Alliances

The BioMed X Institute, Boehringer Ingelheim Launch Call for Research Proposals

Plan to establish an independent research group focused on the development of a New Platform for Next-Generation Intraocular Biologics.

Author Image

By: Charlie Sternberg

Associate Editor

The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim to establish an independent research group focused on the development of a New Platform for Next-Generation Intraocular Biologics. This new initiative marks the second research initiative at the XSeed Labs incubator, located at Boehringer Ingelheim’s research and development site in Ridgefield, Conn. While current biologic therapies have significantly improved the treatme...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters